Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Fixed Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.470.500.420.480.36

What is the latest Fixed Capital/Sales ratio of NGL FINECHEM ?

The latest Fixed Capital/Sales ratio of NGL FINECHEM is 0.47 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.47
Mar20250.50
Mar20240.42
Mar20230.48
Mar20220.36

How is Fixed Capital/Sales of NGL FINECHEM Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.47
-6.00
Mar2025 0.5
19.05
Mar2024 0.42
-12.50
Mar2023 0.48
33.33
Mar2022 0.36 -

Other Financial Ratios of NGL FINECHEM


Compare Fixed Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,866.0 Cr 10.2% 11.9% 103.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,562.0 Cr -3.2% -7.8% 14.1% Stock Analytics
DIVIS LABORATORIES ₹244,572.0 Cr -3.3% -0.2% 63.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,871.0 Cr -2.4% -5% 33.6% Stock Analytics
CIPLA ₹107,770.0 Cr -4% -5.6% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹100,829.0 Cr -1.2% 4.1% -4.2% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

10.2%

11.9%

103.8%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses